Market Snapshot

BSE Sensex: 83576.24 -0.72%
BSE 500: 36807.62 -0.89%
BSE 200: 11620.53 -0.79%
BSE 100: 26904.82 -0.73%
BSE MidCap: 46304.8 -0.90%
BSE SmallCap: 49912.11 -1.74%
BSE BANKEX: 66616.92 -0.58%
BSE IT: 36795.24 0.03%
Nifty 50: 25683.3 -0.75%
Nifty 500: 23467.35 -0.90%
Nifty 200: 14306.95 -0.79%
Nifty 100: 26252.95 -0.79%
Nifty Midcap 100: 59748.15 -0.79%
Nifty Small 100: 17282.65 -1.81%
Nifty IT: 38027.2 0.28%
Nifty PSU Bank: 8601.05 0.18%

News:

Protean eGov Technologies bags...
PTC Industries? arm secures ma...
Globus Spirits reports multi-f...
IREDA Q3 PAT jumps 15% YoY to ...
Tejas Networks reports dismal ...

Shree Ganesh Remedies Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

09 Jan 2026 | 03:59 PM

443.70

-4.15 (-0.93%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-33.7%

Return (1Y)

Underperformed BSE Healthcare by 31.25%
More Volatile

2.7%

Standard Deviation (1Y)

Higher than BSE Healthcare by 1.74%
Inconsistent Performer

2/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

950

418

News & Announcements

Shree Ganesh Remedies consolidated net profit declines 22.62% in the September 2025 quarter
65 days ago

Shree Ganesh Remedies consolidated net profit declines 22.62% in the September 2025 quarter

08 - Nov - 2025 12:00 | 65 days ago

Net profit of Shree Ganesh Remedies declined 22.62% to Rs 4.96 crore in the quarter ended September 2025 as against Rs 6.41 crore during the previous quarter ended September 2024. Sales declined 6.22% to Rs 30.32 crore in the quarter ended September 2025 as against Rs 32.33 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 30.32 32.33 -6

OPM % 31.73 34.98 -

PBDT 9.30 11.06 -16

PBT 6.71 8.64 -22

NP 4.96 6.41 -23

Powered by Capital Market - Live News
Shree Ganesh Remedies standalone net profit declines 22.74% in the September 2025 quarter
66 days ago

Shree Ganesh Remedies standalone net profit declines 22.74% in the September 2025 quarter

07 - Nov - 2025 12:00 | 66 days ago

Net profit of Shree Ganesh Remedies declined 22.74% to Rs 4.96 crore in the quarter ended September 2025 as against Rs 6.42 crore during the previous quarter ended September 2024. Sales declined 6.22% to Rs 30.32 crore in the quarter ended September 2025 as against Rs 32.33 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 30.32 32.33 -6

OPM % 31.76 34.98 -

PBDT 9.31 11.07 -16

PBT 6.72 8.65 -22

NP 4.96 6.42 -23

Powered by Capital Market - Live News
Shree Ganesh Remedies to table results
69 days ago

Shree Ganesh Remedies to table results

04 - Nov - 2025 12:00 | 69 days ago

Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 7 November 2025.
Powered by Capital Market - Live News
Shree Ganesh Remedies AGM scheduled
146 days ago

Shree Ganesh Remedies AGM scheduled

19 - Aug - 2025 12:00 | 146 days ago

Shree Ganesh Remedies announced that the Annual General Meeting(AGM) of the company will be held on 9 September 2025.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Shree Ganesh Remedies Ltd is trading very close to its 52 Week Low
Promoter shareholding in Shree Ganesh Remedies Ltd has increased by 3.26% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	30.32	32.33	-6
OPM %	31.73	34.98	-
PBDT	9.30	11.06	-16
PBT	6.71	8.64	-22
NP	4.96	6.41	-23

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	30.32	32.33	-6
OPM %	31.76	34.98	-
PBDT	9.31	11.07	-16
PBT	6.72	8.65	-22
NP	4.96	6.42	-23

General Notifications

My Notifications

Research Notifications

Shree Ganesh Remedies Ltd Share Price – BSE Pharmaceuticals, Small Cap

443.70 -4.15 (-0.93%)

News & Announcements

Price vs Volume

Stock Trivia

Shree Ganesh Remedies Ltd Share Price – BSE
Pharmaceuticals, Small Cap

443.70

-4.15 (-0.93%)